Neurosteroids and GABAA receptor function

MacDonald, 1994, Annu. Rev. Neurosci., 17, 569, 10.1146/annurev.ne.17.030194.003033

Harrison, 1984, Brain Res., 323, 287, 10.1016/0006-8993(84)90299-3

Barker, 1987, J. Physiol., 386, 485, 10.1113/jphysiol.1987.sp016547

Harrison, 1987, J. Neurosci., 7, 604, 10.1523/JNEUROSCI.07-02-00604.1987

Cottrell, 1987, Br. J. Pharmacol., 90, 491, 10.1111/j.1476-5381.1987.tb11198.x

Callachan, 1987, 231, 359

Peters, 1988, Br. J. Pharmacol., 94, 1257, 10.1111/j.1476-5381.1988.tb11646.x

Morrow, 1990, Mol. Pharmacol., 37, 263

Gee, K. W., McCauley, L. and Lan, N. C. in A Putative Receptor for Neurosteroids on the GABAA Receptor Complex; the Pharmacological Properties and Therapeutic Potential of Epalons, CRC Press (in press)

Hill-Venning, 1994, Vol. 22, 446

Gee, 1988, J. Pharmacol. Exp. Ther., 241, 346

Turner, 1989, J. Pharmacol. Exp. Ther., 248, 960

Lambert, 1991, Vol. 6, 219

Bureau, 1990, Mol. Pharmacol., 37, 497

Twyman, 1992, J. Physiol., 456, 215, 10.1113/jphysiol.1992.sp019334

Mienville, 1989, Brain Res., 489, 190, 10.1016/0006-8993(89)90024-3

Olsen, 1995, Vol. 48, 57

Prince, 1993, Neuropharmacology, 32, 59, 10.1016/0028-3908(93)90130-U

Puia, 1990, Neuron, 4, 759, 10.1016/0896-6273(90)90202-Q

Harris, 1995, Mol. Pharmacol., 47, 363

Hadingham, 1993, Mol. Pharmacol., 44, 1211

Shingai, 1991, Eur. J. Pharmacol.-Mol. Pharmacol. Sect., 206, 77, 10.1016/0922-4106(91)90149-C

Lan, 1991, J. Neurochem., 57, 1818, 10.1111/j.1471-4159.1991.tb06388.x

Puia, 1993, Receptors Channels, 1, 135

Korpi, 1993, Mol. Pharmacol., 44, 87

Chvatal, 1991, Pflügers Arch., 419, 263, 10.1007/BF00371105

Kirkness, 1993, J. Biol. Chem., 268, 4420, 10.1016/S0021-9258(18)53626-7

Gyenes, 1994, Mol. Pharmacol., 46, 542

Woodward, 1992, Mol. Pharmacol., 41, 89

Shimada, 1992, Mol. Pharmacol., 41, 683

Chen, 1994, 91, 6069

Oliver, 1991, Brain Res., 557, 298, 10.1016/0006-8993(91)90148-O

Paul, 1992, FASEB J., 6, 2311, 10.1096/fasebj.6.6.1347506

Wu, 1990, Mol. Pharmacol., 37, 597

Prince, 1992, Neuropharmacology, 31, 201, 10.1016/0028-3908(92)90168-O

Smith, 1994, Prog. Neurobiol., 44, 55, 10.1016/0301-0082(94)90057-4

Park-Chung, 1994, Mol. Pharmacol., 46, 146

French-Mullen, 1994, J. Neurosci., 14, 1963, 10.1523/JNEUROSCI.14-04-01963.1994

Kokate, 1994, J. Pharmacol. Exp. Ther., 270, 1223

Majewska, 1992, Prog. Neurobiol., 38, 379, 10.1016/0301-0082(92)90025-A

Roberts, 1995, Biochem. Pharmacol., 49, 1, 10.1016/0006-2952(94)00258-N

Selye, 1941, 46, 116

Clarke, 1992, Anaesthesia, 47, 285, 10.1111/j.1365-2044.1992.tb02163.x

Carl, 1994, Acta Anaesthesiol. Scand., 38, 734, 10.1111/j.1399-6576.1994.tb03987.x

Van Hemelrijck, 1994, Anesthesiology, 80, 36, 10.1097/00000542-199401000-00009

Finn, 1994, J. Pharmacol. Exp. Ther., 271, 64

McNeil, 1992, Drug News Perspect., 5, 145

Friedman, 1993, Mol. Pharmacol., 44, 191

Stratton, 1994, Br. J. Pharmacol., 113, 34P

Ramsey, 1974, Br. Med. J., 2, 656, 10.1136/bmj.2.5920.656

Belelli, 1994, Br. J. Pharmacol., 112, 1P, 10.1111/j.1476-5381.1994.tb16298.x

Belelli, 1994, Can. J. Physiol. Pharmacol., 72, 339